SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-12-029191
Filing Date
2012-06-07
Accepted
2012-06-07 19:36:37
Documents
1
Period of Report
2012-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1958
  Complete submission text file 0001140361-12-029191.txt   3645
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Issuer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address RAPTOR PHARMACEUTICAL CORP. 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94947
Business Address
Doude van Troostwijk Henk J (Reporting) CIK: 0001551522 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25571 | Film No.: 12896017